 | • レポートコード：MRC2Q12-19349 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、術後鎮痛剤の世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に術後鎮痛剤のグローバル市場のxxx％を占める「オピオイド」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 術後鎮痛剤の中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの術後鎮痛剤市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 術後鎮痛剤のグローバル主要プレイヤーには、Mallinckrodt Pharmaceuticals、Pfizer、Novartis、Eli Lilly、Teva Pharmaceutical Industries、Camurus、Bayer、Pacira BioSciences、Trevenaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 術後鎮痛剤市場は、種類と用途によって区分されます。世界の術後鎮痛剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 オピオイド、NSAID、局所麻酔薬、三環系抗うつ薬、抗てんかん薬、その他 【用途別セグメント】 病院薬局、小売店、オンライン薬局、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 術後鎮痛剤製品概要 - 種類別市場（オピオイド、NSAID、局所麻酔薬、三環系抗うつ薬、抗てんかん薬、その他） - 用途別市場（病院薬局、小売店、オンライン薬局、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の術後鎮痛剤販売量予測2017-2028 - 世界の術後鎮痛剤売上予測2017-2028 - 術後鎮痛剤の地域別販売量 - 術後鎮痛剤の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別術後鎮痛剤販売量 - 主要メーカー別術後鎮痛剤売上 - 主要メーカー別術後鎮痛剤価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（オピオイド、NSAID、局所麻酔薬、三環系抗うつ薬、抗てんかん薬、その他） - 術後鎮痛剤の種類別販売量 - 術後鎮痛剤の種類別売上 - 術後鎮痛剤の種類別価格 ・用途別市場規模（病院薬局、小売店、オンライン薬局、その他） - 術後鎮痛剤の用途別販売量 - 術後鎮痛剤の用途別売上 - 術後鎮痛剤の用途別価格 ・北米市場 - 北米の術後鎮痛剤市場規模（種類別、用途別） - 主要国別の術後鎮痛剤市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの術後鎮痛剤市場規模（種類別、用途別） - 主要国別の術後鎮痛剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の術後鎮痛剤市場規模（種類別、用途別） - 主要国別の術後鎮痛剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の術後鎮痛剤市場規模（種類別、用途別） - 主要国別の術後鎮痛剤市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの術後鎮痛剤市場規模（種類別、用途別） - 主要国別の術後鎮痛剤市場規模（トルコ、サウジアラビア） ・企業情報 Mallinckrodt Pharmaceuticals、Pfizer、Novartis、Eli Lilly、Teva Pharmaceutical Industries、Camurus、Bayer、Pacira BioSciences、Trevena ・産業チェーン及び販売チャネル分析 - 術後鎮痛剤の産業チェーン分析 - 術後鎮痛剤の原材料 - 術後鎮痛剤の生産プロセス - 術後鎮痛剤の販売及びマーケティング - 術後鎮痛剤の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 術後鎮痛剤の産業動向 - 術後鎮痛剤のマーケットドライバー - 術後鎮痛剤の課題 - 術後鎮痛剤の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Postoperative Pain Control is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Postoperative Pain Control is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Postoperative Pain Control is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Postoperative Pain Control include Mallinckrodt Pharmaceuticals, Pfizer, Novartis, Eli Lilly, Teva Pharmaceutical Industries, Camurus, Bayer, Pacira BioSciences and Trevena, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Postoperative Pain Control manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Postoperative Pain Control market. Further, it explains the major drivers and regional dynamics of the global Postoperative Pain Control market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Mallinckrodt Pharmaceuticals
Pfizer
Novartis
Eli Lilly
Teva Pharmaceutical Industries
Camurus
Bayer
Pacira BioSciences
Trevena
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Postoperative Pain Control Segment by Type
Opioids
NSAIDs
Local Anesthetics
Tricyclic Antidepressants
Antiepileptic drugs
Others
Postoperative Pain Control Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Postoperative Pain Control market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Postoperative Pain Control, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Postoperative Pain Control, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Postoperative Pain Control, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Postoperative Pain Control sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Postoperative Pain Control market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Postoperative Pain Control sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Mallinckrodt Pharmaceuticals, Pfizer, Novartis, Eli Lilly, Teva Pharmaceutical Industries, Camurus, Bayer, Pacira BioSciences and Trevena, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Postoperative Pain Control in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Postoperative Pain Control manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Postoperative Pain Control sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Postoperative Pain Control Product Introduction
1.2 Market by Type
1.2.1 Global Postoperative Pain Control Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Opioids
1.2.3 NSAIDs
1.2.4 Local Anesthetics
1.2.5 Tricyclic Antidepressants
1.2.6 Antiepileptic drugs
1.2.7 Others
1.3 Market by Application
1.3.1 Global Postoperative Pain Control Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Postoperative Pain Control Sales Estimates and Forecasts 2017-2028
2.2 Global Postoperative Pain Control Revenue Estimates and Forecasts 2017-2028
2.3 Global Postoperative Pain Control Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Postoperative Pain Control Sales by Region
2.4.1 Global Postoperative Pain Control Sales by Region (2017-2022)
2.4.2 Global Sales Postoperative Pain Control by Region (2023-2028)
2.5 Global Postoperative Pain Control Revenue by Region
2.5.1 Global Postoperative Pain Control Revenue by Region (2017-2022)
2.5.2 Global Postoperative Pain Control Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Postoperative Pain Control Sales by Manufacturers
3.1.1 Global Top Postoperative Pain Control Manufacturers by Sales (2017-2022)
3.1.2 Global Postoperative Pain Control Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Postoperative Pain Control in 2021
3.2 Global Postoperative Pain Control Revenue by Manufacturers
3.2.1 Global Postoperative Pain Control Revenue by Manufacturers (2017-2022)
3.2.2 Global Postoperative Pain Control Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Postoperative Pain Control Revenue in 2021
3.3 Global Postoperative Pain Control Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Postoperative Pain Control Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Postoperative Pain Control Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Postoperative Pain Control Sales by Type
4.1.1 Global Postoperative Pain Control Historical Sales by Type (2017-2022)
4.1.2 Global Postoperative Pain Control Forecasted Sales by Type (2023-2028)
4.1.3 Global Postoperative Pain Control Sales Market Share by Type (2017-2028)
4.2 Global Postoperative Pain Control Revenue by Type
4.2.1 Global Postoperative Pain Control Historical Revenue by Type (2017-2022)
4.2.2 Global Postoperative Pain Control Forecasted Revenue by Type (2023-2028)
4.2.3 Global Postoperative Pain Control Revenue Market Share by Type (2017-2028)
4.3 Global Postoperative Pain Control Price by Type
4.3.1 Global Postoperative Pain Control Price by Type (2017-2022)
4.3.2 Global Postoperative Pain Control Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Postoperative Pain Control Sales by Application
5.1.1 Global Postoperative Pain Control Historical Sales by Application (2017-2022)
5.1.2 Global Postoperative Pain Control Forecasted Sales by Application (2023-2028)
5.1.3 Global Postoperative Pain Control Sales Market Share by Application (2017-2028)
5.2 Global Postoperative Pain Control Revenue by Application
5.2.1 Global Postoperative Pain Control Historical Revenue by Application (2017-2022)
5.2.2 Global Postoperative Pain Control Forecasted Revenue by Application (2023-2028)
5.2.3 Global Postoperative Pain Control Revenue Market Share by Application (2017-2028)
5.3 Global Postoperative Pain Control Price by Application
5.3.1 Global Postoperative Pain Control Price by Application (2017-2022)
5.3.2 Global Postoperative Pain Control Price Forecast by Application (2023-2028)
6 North America
6.1 North America Postoperative Pain Control Market Size by Type
6.1.1 North America Postoperative Pain Control Sales by Type (2017-2028)
6.1.2 North America Postoperative Pain Control Revenue by Type (2017-2028)
6.2 North America Postoperative Pain Control Market Size by Application
6.2.1 North America Postoperative Pain Control Sales by Application (2017-2028)
6.2.2 North America Postoperative Pain Control Revenue by Application (2017-2028)
6.3 North America Postoperative Pain Control Market Size by Country
6.3.1 North America Postoperative Pain Control Sales by Country (2017-2028)
6.3.2 North America Postoperative Pain Control Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Postoperative Pain Control Market Size by Type
7.1.1 Europe Postoperative Pain Control Sales by Type (2017-2028)
7.1.2 Europe Postoperative Pain Control Revenue by Type (2017-2028)
7.2 Europe Postoperative Pain Control Market Size by Application
7.2.1 Europe Postoperative Pain Control Sales by Application (2017-2028)
7.2.2 Europe Postoperative Pain Control Revenue by Application (2017-2028)
7.3 Europe Postoperative Pain Control Market Size by Country
7.3.1 Europe Postoperative Pain Control Sales by Country (2017-2028)
7.3.2 Europe Postoperative Pain Control Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Postoperative Pain Control Market Size by Type
8.1.1 Asia Pacific Postoperative Pain Control Sales by Type (2017-2028)
8.1.2 Asia Pacific Postoperative Pain Control Revenue by Type (2017-2028)
8.2 Asia Pacific Postoperative Pain Control Market Size by Application
8.2.1 Asia Pacific Postoperative Pain Control Sales by Application (2017-2028)
8.2.2 Asia Pacific Postoperative Pain Control Revenue by Application (2017-2028)
8.3 Asia Pacific Postoperative Pain Control Market Size by Region
8.3.1 Asia Pacific Postoperative Pain Control Sales by Region (2017-2028)
8.3.2 Asia Pacific Postoperative Pain Control Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Postoperative Pain Control Market Size by Type
9.1.1 Latin America Postoperative Pain Control Sales by Type (2017-2028)
9.1.2 Latin America Postoperative Pain Control Revenue by Type (2017-2028)
9.2 Latin America Postoperative Pain Control Market Size by Application
9.2.1 Latin America Postoperative Pain Control Sales by Application (2017-2028)
9.2.2 Latin America Postoperative Pain Control Revenue by Application (2017-2028)
9.3 Latin America Postoperative Pain Control Market Size by Country
9.3.1 Latin America Postoperative Pain Control Sales by Country (2017-2028)
9.3.2 Latin America Postoperative Pain Control Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Postoperative Pain Control Market Size by Type
10.1.1 Middle East and Africa Postoperative Pain Control Sales by Type (2017-2028)
10.1.2 Middle East and Africa Postoperative Pain Control Revenue by Type (2017-2028)
10.2 Middle East and Africa Postoperative Pain Control Market Size by Application
10.2.1 Middle East and Africa Postoperative Pain Control Sales by Application (2017-2028)
10.2.2 Middle East and Africa Postoperative Pain Control Revenue by Application (2017-2028)
10.3 Middle East and Africa Postoperative Pain Control Market Size by Country
10.3.1 Middle East and Africa Postoperative Pain Control Sales by Country (2017-2028)
10.3.2 Middle East and Africa Postoperative Pain Control Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Mallinckrodt Pharmaceuticals
11.1.1 Mallinckrodt Pharmaceuticals Corporation Information
11.1.2 Mallinckrodt Pharmaceuticals Overview
11.1.3 Mallinckrodt Pharmaceuticals Postoperative Pain Control Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Mallinckrodt Pharmaceuticals Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Mallinckrodt Pharmaceuticals Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Postoperative Pain Control Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Postoperative Pain Control Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Corporation Information
11.4.2 Eli Lilly Overview
11.4.3 Eli Lilly Postoperative Pain Control Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Lilly Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly Recent Developments
11.5 Teva Pharmaceutical Industries
11.5.1 Teva Pharmaceutical Industries Corporation Information
11.5.2 Teva Pharmaceutical Industries Overview
11.5.3 Teva Pharmaceutical Industries Postoperative Pain Control Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Teva Pharmaceutical Industries Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Teva Pharmaceutical Industries Recent Developments
11.6 Camurus
11.6.1 Camurus Corporation Information
11.6.2 Camurus Overview
11.6.3 Camurus Postoperative Pain Control Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Camurus Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Camurus Recent Developments
11.7 Bayer
11.7.1 Bayer Corporation Information
11.7.2 Bayer Overview
11.7.3 Bayer Postoperative Pain Control Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bayer Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bayer Recent Developments
11.8 Pacira BioSciences
11.8.1 Pacira BioSciences Corporation Information
11.8.2 Pacira BioSciences Overview
11.8.3 Pacira BioSciences Postoperative Pain Control Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pacira BioSciences Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pacira BioSciences Recent Developments
11.9 Trevena
11.9.1 Trevena Corporation Information
11.9.2 Trevena Overview
11.9.3 Trevena Postoperative Pain Control Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Trevena Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Trevena Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Postoperative Pain Control Industry Chain Analysis
12.2 Postoperative Pain Control Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Postoperative Pain Control Production Mode & Process
12.4 Postoperative Pain Control Sales and Marketing
12.4.1 Postoperative Pain Control Sales Channels
12.4.2 Postoperative Pain Control Distributors
12.5 Postoperative Pain Control Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Postoperative Pain Control Industry Trends
13.2 Postoperative Pain Control Market Drivers
13.3 Postoperative Pain Control Market Challenges
13.4 Postoperative Pain Control Market Restraints
14 Key Findings in The Global Postoperative Pain Control Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Postoperative Pain Control Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Opioids
Table 3. Major Manufacturers of NSAIDs
Table 4. Major Manufacturers of Local Anesthetics
Table 5. Major Manufacturers of Tricyclic Antidepressants
Table 6. Major Manufacturers of Antiepileptic drugs
Table 7. Major Manufacturers of Others
Table 8. Global Postoperative Pain Control Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Postoperative Pain Control Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Postoperative Pain Control Sales by Region (2017-2022) & (K Units)
Table 11. Global Postoperative Pain Control Sales Market Share by Region (2017-2022)
Table 12. Global Postoperative Pain Control Sales by Region (2023-2028) & (K Units)
Table 13. Global Postoperative Pain Control Sales Market Share by Region (2023-2028)
Table 14. Global Postoperative Pain Control Revenue by Region (2017-2022) & (US$ Million)
Table 15. Global Postoperative Pain Control Revenue Market Share by Region (2017-2022)
Table 16. Global Postoperative Pain Control Revenue by Region (2023-2028) & (US$ Million)
Table 17. Global Postoperative Pain Control Revenue Market Share by Region (2023-2028)
Table 18. Global Postoperative Pain Control Sales by Manufacturers (2017-2022) & (K Units)
Table 19. Global Postoperative Pain Control Sales Share by Manufacturers (2017-2022)
Table 20. Global Postoperative Pain Control Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 21. Global Postoperative Pain Control Revenue Share by Manufacturers (2017-2022)
Table 22. Postoperative Pain Control Price by Manufacturers (2017-2022) &(US$/Unit)
Table 23. Global Postoperative Pain Control Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Postoperative Pain Control by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postoperative Pain Control as of 2021)
Table 25. Postoperative Pain Control Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Postoperative Pain Control Product Offered
Table 27. Date of Manufacturers Enter into Postoperative Pain Control Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Postoperative Pain Control Sales by Type (2017-2022) & (K Units)
Table 30. Global Postoperative Pain Control Sales by Type (2023-2028) & (K Units)
Table 31. Global Postoperative Pain Control Sales Share by Type (2017-2022)
Table 32. Global Postoperative Pain Control Sales Share by Type (2023-2028)
Table 33. Global Postoperative Pain Control Revenue by Type (2017-2022) & (US$ Million)
Table 34. Global Postoperative Pain Control Revenue by Type (2023-2028) & (US$ Million)
Table 35. Global Postoperative Pain Control Revenue Share by Type (2017-2022)
Table 36. Global Postoperative Pain Control Revenue Share by Type (2023-2028)
Table 37. Postoperative Pain Control Price by Type (2017-2022) & (US$/Unit)
Table 38. Global Postoperative Pain Control Price Forecast by Type (2023-2028) & (US$/Unit)
Table 39. Global Postoperative Pain Control Sales by Application (2017-2022) & (K Units)
Table 40. Global Postoperative Pain Control Sales by Application (2023-2028) & (K Units)
Table 41. Global Postoperative Pain Control Sales Share by Application (2017-2022)
Table 42. Global Postoperative Pain Control Sales Share by Application (2023-2028)
Table 43. Global Postoperative Pain Control Revenue by Application (2017-2022) & (US$ Million)
Table 44. Global Postoperative Pain Control Revenue by Application (2023-2028) & (US$ Million)
Table 45. Global Postoperative Pain Control Revenue Share by Application (2017-2022)
Table 46. Global Postoperative Pain Control Revenue Share by Application (2023-2028)
Table 47. Postoperative Pain Control Price by Application (2017-2022) & (US$/Unit)
Table 48. Global Postoperative Pain Control Price Forecast by Application (2023-2028) & (US$/Unit)
Table 49. North America Postoperative Pain Control Sales by Type (2017-2022) & (K Units)
Table 50. North America Postoperative Pain Control Sales by Type (2023-2028) & (K Units)
Table 51. North America Postoperative Pain Control Revenue by Type (2017-2022) & (US$ Million)
Table 52. North America Postoperative Pain Control Revenue by Type (2023-2028) & (US$ Million)
Table 53. North America Postoperative Pain Control Sales by Application (2017-2022) & (K Units)
Table 54. North America Postoperative Pain Control Sales by Application (2023-2028) & (K Units)
Table 55. North America Postoperative Pain Control Revenue by Application (2017-2022) & (US$ Million)
Table 56. North America Postoperative Pain Control Revenue by Application (2023-2028) & (US$ Million)
Table 57. North America Postoperative Pain Control Sales by Country (2017-2022) & (K Units)
Table 58. North America Postoperative Pain Control Sales by Country (2023-2028) & (K Units)
Table 59. North America Postoperative Pain Control Revenue by Country (2017-2022) & (US$ Million)
Table 60. North America Postoperative Pain Control Revenue by Country (2023-2028) & (US$ Million)
Table 61. Europe Postoperative Pain Control Sales by Type (2017-2022) & (K Units)
Table 62. Europe Postoperative Pain Control Sales by Type (2023-2028) & (K Units)
Table 63. Europe Postoperative Pain Control Revenue by Type (2017-2022) & (US$ Million)
Table 64. Europe Postoperative Pain Control Revenue by Type (2023-2028) & (US$ Million)
Table 65. Europe Postoperative Pain Control Sales by Application (2017-2022) & (K Units)
Table 66. Europe Postoperative Pain Control Sales by Application (2023-2028) & (K Units)
Table 67. Europe Postoperative Pain Control Revenue by Application (2017-2022) & (US$ Million)
Table 68. Europe Postoperative Pain Control Revenue by Application (2023-2028) & (US$ Million)
Table 69. Europe Postoperative Pain Control Sales by Country (2017-2022) & (K Units)
Table 70. Europe Postoperative Pain Control Sales by Country (2023-2028) & (K Units)
Table 71. Europe Postoperative Pain Control Revenue by Country (2017-2022) & (US$ Million)
Table 72. Europe Postoperative Pain Control Revenue by Country (2023-2028) & (US$ Million)
Table 73. Asia Pacific Postoperative Pain Control Sales by Type (2017-2022) & (K Units)
Table 74. Asia Pacific Postoperative Pain Control Sales by Type (2023-2028) & (K Units)
Table 75. Asia Pacific Postoperative Pain Control Revenue by Type (2017-2022) & (US$ Million)
Table 76. Asia Pacific Postoperative Pain Control Revenue by Type (2023-2028) & (US$ Million)
Table 77. Asia Pacific Postoperative Pain Control Sales by Application (2017-2022) & (K Units)
Table 78. Asia Pacific Postoperative Pain Control Sales by Application (2023-2028) & (K Units)
Table 79. Asia Pacific Postoperative Pain Control Revenue by Application (2017-2022) & (US$ Million)
Table 80. Asia Pacific Postoperative Pain Control Revenue by Application (2023-2028) & (US$ Million)
Table 81. Asia Pacific Postoperative Pain Control Sales by Region (2017-2022) & (K Units)
Table 82. Asia Pacific Postoperative Pain Control Sales by Region (2023-2028) & (K Units)
Table 83. Asia Pacific Postoperative Pain Control Revenue by Region (2017-2022) & (US$ Million)
Table 84. Asia Pacific Postoperative Pain Control Revenue by Region (2023-2028) & (US$ Million)
Table 85. Latin America Postoperative Pain Control Sales by Type (2017-2022) & (K Units)
Table 86. Latin America Postoperative Pain Control Sales by Type (2023-2028) & (K Units)
Table 87. Latin America Postoperative Pain Control Revenue by Type (2017-2022) & (US$ Million)
Table 88. Latin America Postoperative Pain Control Revenue by Type (2023-2028) & (US$ Million)
Table 89. Latin America Postoperative Pain Control Sales by Application (2017-2022) & (K Units)
Table 90. Latin America Postoperative Pain Control Sales by Application (2023-2028) & (K Units)
Table 91. Latin America Postoperative Pain Control Revenue by Application (2017-2022) & (US$ Million)
Table 92. Latin America Postoperative Pain Control Revenue by Application (2023-2028) & (US$ Million)
Table 93. Latin America Postoperative Pain Control Sales by Country (2017-2022) & (K Units)
Table 94. Latin America Postoperative Pain Control Sales by Country (2023-2028) & (K Units)
Table 95. Latin America Postoperative Pain Control Revenue by Country (2017-2022) & (US$ Million)
Table 96. Latin America Postoperative Pain Control Revenue by Country (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Postoperative Pain Control Sales by Type (2017-2022) & (K Units)
Table 98. Middle East and Africa Postoperative Pain Control Sales by Type (2023-2028) & (K Units)
Table 99. Middle East and Africa Postoperative Pain Control Revenue by Type (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Postoperative Pain Control Revenue by Type (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Postoperative Pain Control Sales by Application (2017-2022) & (K Units)
Table 102. Middle East and Africa Postoperative Pain Control Sales by Application (2023-2028) & (K Units)
Table 103. Middle East and Africa Postoperative Pain Control Revenue by Application (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Postoperative Pain Control Revenue by Application (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Postoperative Pain Control Sales by Country (2017-2022) & (K Units)
Table 106. Middle East and Africa Postoperative Pain Control Sales by Country (2023-2028) & (K Units)
Table 107. Middle East and Africa Postoperative Pain Control Revenue by Country (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Postoperative Pain Control Revenue by Country (2023-2028) & (US$ Million)
Table 109. Mallinckrodt Pharmaceuticals Corporation Information
Table 110. Mallinckrodt Pharmaceuticals Description and Major Businesses
Table 111. Mallinckrodt Pharmaceuticals Postoperative Pain Control Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Mallinckrodt Pharmaceuticals Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Mallinckrodt Pharmaceuticals Recent Developments
Table 114. Pfizer Corporation Information
Table 115. Pfizer Description and Major Businesses
Table 116. Pfizer Postoperative Pain Control Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Pfizer Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Pfizer Recent Developments
Table 119. Novartis Corporation Information
Table 120. Novartis Description and Major Businesses
Table 121. Novartis Postoperative Pain Control Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Novartis Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Novartis Recent Developments
Table 124. Eli Lilly Corporation Information
Table 125. Eli Lilly Description and Major Businesses
Table 126. Eli Lilly Postoperative Pain Control Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Eli Lilly Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Eli Lilly Recent Developments
Table 129. Teva Pharmaceutical Industries Corporation Information
Table 130. Teva Pharmaceutical Industries Description and Major Businesses
Table 131. Teva Pharmaceutical Industries Postoperative Pain Control Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Teva Pharmaceutical Industries Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Teva Pharmaceutical Industries Recent Developments
Table 134. Camurus Corporation Information
Table 135. Camurus Description and Major Businesses
Table 136. Camurus Postoperative Pain Control Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Camurus Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Camurus Recent Developments
Table 139. Bayer Corporation Information
Table 140. Bayer Description and Major Businesses
Table 141. Bayer Postoperative Pain Control Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. Bayer Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Bayer Recent Developments
Table 144. Pacira BioSciences Corporation Information
Table 145. Pacira BioSciences Description and Major Businesses
Table 146. Pacira BioSciences Postoperative Pain Control Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 147. Pacira BioSciences Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Pacira BioSciences Recent Developments
Table 149. Trevena Corporation Information
Table 150. Trevena Description and Major Businesses
Table 151. Trevena Postoperative Pain Control Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 152. Trevena Postoperative Pain Control Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Trevena Recent Developments
Table 154. Key Raw Materials Lists
Table 155. Raw Materials Key Suppliers Lists
Table 156. Postoperative Pain Control Distributors List
Table 157. Postoperative Pain Control Customers List
Table 158. Postoperative Pain Control Market Trends
Table 159. Postoperative Pain Control Market Drivers
Table 160. Postoperative Pain Control Market Challenges
Table 161. Postoperative Pain Control Market Restraints
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Postoperative Pain Control Product Picture
Figure 2. Global Postoperative Pain Control Market Share by Type in 2021 & 2028
Figure 3. Opioids Product Picture
Figure 4. NSAIDs Product Picture
Figure 5. Local Anesthetics Product Picture
Figure 6. Tricyclic Antidepressants Product Picture
Figure 7. Antiepileptic drugs Product Picture
Figure 8. Others Product Picture
Figure 9. Global Postoperative Pain Control Market Share by Application in 2021 & 2028
Figure 10. Hospital Pharmacies
Figure 11. Retail Pharmacies
Figure 12. Online Pharmacies
Figure 13. Others
Figure 14. Postoperative Pain Control Report Years Considered
Figure 15. Global Postoperative Pain Control Sales 2017-2028 (K Units)
Figure 16. Global Postoperative Pain Control Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Postoperative Pain Control Revenue 2017-2028 (US$ Million)
Figure 18. Global Postoperative Pain Control Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 19. Global Postoperative Pain Control Sales Market Share by Region (2017-2022)
Figure 20. Global Postoperative Pain Control Sales Market Share by Region (2023-2028)
Figure 21. North America Postoperative Pain Control Sales YoY (2017-2028) & (K Units)
Figure 22. North America Postoperative Pain Control Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Europe Postoperative Pain Control Sales YoY (2017-2028) & (K Units)
Figure 24. Europe Postoperative Pain Control Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Asia-Pacific Postoperative Pain Control Sales YoY (2017-2028) & (K Units)
Figure 26. Asia-Pacific Postoperative Pain Control Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Latin America Postoperative Pain Control Sales YoY (2017-2028) & (K Units)
Figure 28. Latin America Postoperative Pain Control Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Middle East & Africa Postoperative Pain Control Sales YoY (2017-2028) & (K Units)
Figure 30. Middle East & Africa Postoperative Pain Control Revenue YoY (2017-2028) & (US$ Million)
Figure 31. The Postoperative Pain Control Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 32. The Top 5 and 10 Largest Manufacturers of Postoperative Pain Control in the World: Market Share by Postoperative Pain Control Revenue in 2021
Figure 33. Global Postoperative Pain Control Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 34. Global Postoperative Pain Control Sales Market Share by Type (2017-2028)
Figure 35. Global Postoperative Pain Control Revenue Market Share by Type (2017-2028)
Figure 36. Global Postoperative Pain Control Sales Market Share by Application (2017-2028)
Figure 37. Global Postoperative Pain Control Revenue Market Share by Application (2017-2028)
Figure 38. North America Postoperative Pain Control Sales Market Share by Type (2017-2028)
Figure 39. North America Postoperative Pain Control Revenue Market Share by Type (2017-2028)
Figure 40. North America Postoperative Pain Control Sales Market Share by Application (2017-2028)
Figure 41. North America Postoperative Pain Control Revenue Market Share by Application (2017-2028)
Figure 42. North America Postoperative Pain Control Sales Share by Country (2017-2028)
Figure 43. North America Postoperative Pain Control Revenue Share by Country (2017-2028)
Figure 44. United States Postoperative Pain Control Revenue (2017-2028) & (US$ Million)
Figure 45. Canada Postoperative Pain Control Revenue (2017-2028) & (US$ Million)
Figure 46. Europe Postoperative Pain Control Sales Market Share by Type (2017-2028)
Figure 47. Europe Postoperative Pain Control Revenue Market Share by Type (2017-2028)
Figure 48. Europe Postoperative Pain Control Sales Market Share by Application (2017-2028)
Figure 49. Europe Postoperative Pain Control Revenue Market Share by Application (2017-2028)
Figure 50. Europe Postoperative Pain Control Sales Share by Country (2017-2028)
Figure 51. Europe Postoperative Pain Control Revenue Share by Country (2017-2028)
Figure 52. Germany Postoperative Pain Control Revenue (2017-2028) & (US$ Million)
Figure 53. France Postoperative Pain Control Revenue (2017-2028) & (US$ Million)
Figure 54. U.K. Postoperative Pain Control Revenue (2017-2028) & (US$ Million)
Figure 55. Italy Postoperative Pain Control Revenue (2017-2028) & (US$ Million)
Figure 56. Russia Postoperative Pain Control Revenue (2017-2028) & (US$ Million)
Figure 57. Asia Pacific Postoperative Pain Control Sales Market Share by Type (2017-2028)
Figure 58. Asia Pacific Postoperative Pain Control Revenue Market Share by Type (2017-2028)
Figure 59. Asia Pacific Postoperative Pain Control Sales Market Share by Application (2017-2028)
Figure 60. Asia Pacific Postoperative Pain Control Revenue Market Share by Application (2017-2028)
Figure 61. Asia Pacific Postoperative Pain Control Sales Share by Region (2017-2028)
Figure 62. Asia Pacific Postoperative Pain Control Revenue Share by Region (2017-2028)
Figure 63. China Postoperative Pain Control Revenue (2017-2028) & (US$ Million)
Figure 64. Japan Postoperative Pain Control Revenue (2017-2028) & (US$ Million)
Figure 65. South Korea Postoperative Pain Control Revenue (2017-2028) & (US$ Million)
Figure 66. India Postoperative Pain Control Revenue (2017-2028) & (US$ Million)
Figure 67. Australia Postoperative Pain Control Revenue (2017-2028) & (US$ Million)
Figure 68. China Taiwan Postoperative Pain Control Revenue (2017-2028) & (US$ Million)
Figure 69. Indonesia Postoperative Pain Control Revenue (2017-2028) & (US$ Million)
Figure 70. Thailand Postoperative Pain Control Revenue (2017-2028) & (US$ Million)
Figure 71. Malaysia Postoperative Pain Control Revenue (2017-2028) & (US$ Million)
Figure 72. Latin America Postoperative Pain Control Sales Market Share by Type (2017-2028)
Figure 73. Latin America Postoperative Pain Control Revenue Market Share by Type (2017-2028)
Figure 74. Latin America Postoperative Pain Control Sales Market Share by Application (2017-2028)
Figure 75. Latin America Postoperative Pain Control Revenue Market Share by Application (2017-2028)
Figure 76. Latin America Postoperative Pain Control Sales Share by Country (2017-2028)
Figure 77. Latin America Postoperative Pain Control Revenue Share by Country (2017-2028)
Figure 78. Mexico Postoperative Pain Control Revenue (2017-2028) & (US$ Million)
Figure 79. Brazil Postoperative Pain Control Revenue (2017-2028) & (US$ Million)
Figure 80. Argentina Postoperative Pain Control Revenue (2017-2028) & (US$ Million)
Figure 81. Middle East and Africa Postoperative Pain Control Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Postoperative Pain Control Revenue Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Postoperative Pain Control Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Postoperative Pain Control Revenue Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Postoperative Pain Control Sales Share by Country (2017-2028)
Figure 86. Middle East and Africa Postoperative Pain Control Revenue Share by Country (2017-2028)
Figure 87. Turkey Postoperative Pain Control Revenue (2017-2028) & (US$ Million)
Figure 88. Saudi Arabia Postoperative Pain Control Revenue (2017-2028) & (US$ Million)
Figure 89. UAE Postoperative Pain Control Revenue (2017-2028) & (US$ Million)
Figure 90. Postoperative Pain Control Value Chain
Figure 91. Postoperative Pain Control Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed